Colgate-Palmolive Company (CL)

Colgate-Palmolive Company is a New York-based consumer staples company listed on the NYSE as common stock under the ticker CL. Through its subsidiaries, the company develops and sells household and personal care products in the United States and abroad. Its business is organized into two segments: Oral, Personal and Home Care, and Pet Nutrition. The first segment includes oral care, soaps, shower products, shampoos, skin health items, household cleaning products, and related products sold under brands such as Colgate, Palmolive, Softsoap, Speed Stick, Ajax, Fabuloso, and several others. The Pet Nutrition segment markets Hill’s Science Diet, Hill’s Prescription Diet, and Prime100 products through pet retailers, veterinarians, and online channels. Founded in 1806, the company is headquartered in New York, New York.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CL
$92.62
2.6% Upside
Fair
$97.65
8.1% Upside
Fair
Good
July 20, 2026
August 14, 2026
2.12
2.3%
July 31, 2026
34.6x
498.4x
3.5x
73.561 B
79.16 B
9.7%
93.8%
8.8
87.8%
180.4%
Valuation • Fair Value

Colgate-Palmolive Company (NYSE-CL) Fair Value by Valuation Model

Compare the primary fair value estimate for Colgate-Palmolive Company (NYSE-CL) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$92.62

Estimated upside of 2.6% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$99.44

Discounted cash flow valuation reference.

Ben Graham Formula Value

$28.95

Classic Ben Graham valuation formula reference.

DDM Fair Value

$101.66

Dividend discount model valuation reference.

EPV Fair Value

$67.66

Earnings power value estimate.

Comps Fair Value

$86.94

Comparable-company valuation reference.

Analyst Price Target

$97.65

Analysts imply upside of 8.1%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Colgate-Palmolive Company (NYSE-CL) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Colgate-Palmolive Company (NYSE-CL)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

20.795 B

Current operating scale indicator.

Revenue Forecast

21.412 B

Forward revenue estimate.

EBITDA

4.921 B

Current operating profitability reference.

EBITDA Forecast

5.082 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Colgate-Palmolive Company (NYSE-CL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Colgate-Palmolive Company (NYSE-CL)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-3.03

No elevated caution signal from this screen.

Altman Z-Score

8.8

Relatively strong balance-sheet zone.

FCF / Net Income

180.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Colgate-Palmolive Company (NYSE-CL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Colgate-Palmolive Company (NYSE-CL)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 31, 2026

Days to Earnings

10

Dividend Payment Date

August 14, 2026

Ex-Dividend Date

July 20, 2026

Dividend Yield

2.3%

Income yield reference.

Upcoming Dividend

2.12

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

87.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Colgate-Palmolive Company (NYSE-CL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Colgate-Palmolive Company (NYSE-CL) Stock Forecast & Technical Outlook

Review Colgate-Palmolive Company (NYSE-CL) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Colgate-Palmolive Company (NYSE-CL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Colgate-Palmolive Company (NYSE-CL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Colgate-Palmolive Company (NYSE-CL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Colgate-Palmolive Company (NYSE-CL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Colgate-Palmolive Company (NYSE-CL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Colgate-Palmolive Company (NYSE-CL)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Colgate-Palmolive Company (NYSE-CL) has a Buy consensus, with 7 buy, 7 hold and 0 sell recommendations in the current data set.

Buy 7
Hold 7
Sell 0
FAQ Fast Investor Answers

Colgate-Palmolive Company (NYSE-CL) Stock FAQ

Quick answers about Colgate-Palmolive Company (NYSE-CL) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$92.62
Estimated upside 2.6%
Valuation Rating
Undervalued
Estimated upside of 2.6%
Analyst Target
$97.65
Implied upside 8.1%
Financial Health
Good
Current financial-health read

The current fair value estimate for Colgate-Palmolive Company (NYSE-CL) is $92.62. This implies an estimated upside of 2.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 2.6% versus the current market price.

The available analyst price target for Colgate-Palmolive Company (NYSE-CL) is $97.65. The analyst target implies estimated upside of 8.1%.

The current financial health read for Colgate-Palmolive Company (NYSE-CL) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Colgate-Palmolive Company (NYSE-CL) is July 31, 2026.

Based on the current data, dividend yield is 2.3%, upcoming dividend amount is 2.12, ex-dividend date is July 20, 2026, payment date is August 14, 2026.

The current P/E ratio listed for Colgate-Palmolive Company (NYSE-CL) is 34.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Colgate-Palmolive Company is 73.561 B.

The current enterprise value listed for Colgate-Palmolive Company is 79.16 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Colgate-Palmolive Company is NYSE-CL, and the stock is listed on NYSE.

Colgate-Palmolive Company (NYSE-CL) is listed on NYSE.

The current debt-to-total-capital ratio listed for Colgate-Palmolive Company is 9.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Colgate-Palmolive Company is 93.8%. Free float helps investors understand how much of the share base is available for public trading.